Results 21 to 30 of about 582,852 (293)
PHOSPHATE BINDER THERAPY AND SERUM PHOSPHATE CONTROL FOLLOWING INITIATION OF HAEMODIALYSIS
Hyperphosphataemia is associated with increased all-cause mortality in patients with chronic kidney disease (CKD), but serum phosphate (P) levels can be managed by dialysis, diet and the use of P binders. Serum P data were obtained retrospectively from a
Kimberly Farrand +5 more
doaj +1 more source
Համառոտագիր Հոդվածը նվիրված է տեղական հումքով՝ Սևանի մագնեզիումասիլիկատային ապարներով, հրակայուն և կրակակայուն բետոնների ստացման տեխնոլոգիաների մշակմանը, որոնք կարող են օգտագործվել ջերմային ագրեգատներում՝ փոխարինելով շարվածքի մանրահատ աղյուսներին ու
Amalya Karapetyan, Maria Badalyan
doaj +1 more source
FERRIC CITRATE: AN IRON-BASED ORAL PHOSPHATE BINDER
Patients with end-stage renal disease (ESRD) often experience secondary bone and mineral disorder requiring treatment with phosphate-binder (PB) medications, vitamin D sterols, and calcimimetics.
T. Christopher Bond +4 more
doaj +1 more source
Gut dysbiosis in patients with chronic kidney disease (CKD) may induce chronic inflammation and increase morbidity. Phosphate-binding agents, generally used in patients with CKD, may potentially change the composition of the gut microbiota.
Ping-Hsun Wu +9 more
doaj +1 more source
Treatment of chronic kidney disease (CKD) mineral bone disorder (MBD) is challenging in growing children due to the high amount of calcium needed for normal bone mineralization and the required dietary phosphate restriction, which often includes intake ...
Lilith Schmitz +8 more
doaj +1 more source
Sevelamer Carbonate Crystal-Induced Colitis
Hyperphosphatemia is a common and well-described complication of end-stage renal disease. Despite strict dietary constraints and compliance, phosphate binders such as calcium acetate and/or sevelamer carbonate are also needed to treat secondary ...
T. Lai +3 more
doaj +1 more source
The impact of nurse-led education on haemodialysis patients' phosphate binder medication adherence
Background: Phosphate binder medication adherence is required to maintain optimal phosphate levels and minimise bone disease in people with end stage kidney disease.Objectives: To examine the impact of a nurse‐led education intervention on bone disorder ...
Sandlin, K. +3 more
core +2 more sources
Background: Chronic kidney disease (CKD) is a life-threatening disease with numerous complications. Hemodialysis (HD) patients are prone to magnesium deficiency due to malnutrition, which can cause cardiovascular complications and increase mortality. The
Elahe Jandaghi +5 more
doaj +1 more source
This work aims to assess the influence of the chemical composition of the binder resulting from the reaction of phosphoric acid and volcanic ash on its final characteristics. Six initial compositions of volcanic ash phosphate geopolymer with molar ratios
Stephan, Dietmar +1 more
core +1 more source
Colon Perforation in the Setting of Sevelamer Crystals
Sevelamer is frequently used as a phosphate binder in patients with end-stage renal disease. It can also cause gastrointestinal side effects including colitis, obstruction, and, rarely, perforation.
Gregory Shinaman +4 more
doaj +1 more source

